Docetaxel and carboplatin followed by sequential capecitabine as first line treatment in patients with locally advanced or metastatic breast cancer.

Mapping Intimacies ◽

10.1158/0008-5472.sabcs-2155 ◽

2009 ◽

Author(s):

A Lorenzo ◽

A Modolell ◽

P Valero ◽

L Murillo ◽

JM García-Bueno ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Locally Advanced ◽

Metastatic Breast ◽

Line Treatment ◽

First Line Treatment

Download Full-text

Abstract P2-16-10: Safety of pertuzumab plus trastuzumab plus vinorelbine for first-line treatment of patients with HER2-positive locally advanced or metastatic breast cancer

10.1158/0008-5472.sabcs13-p2-16-10 ◽

2013 ◽

Author(s):

EA Perez ◽

JM López-Vega ◽

L Del Mastro ◽

T Petit ◽

C Zamagni ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Locally Advanced ◽

Metastatic Breast ◽

Line Treatment ◽

Her2 Positive ◽

First Line Treatment

Download Full-text

Abstract PS10-16: Real-world efficacy of ribociclib + aromatase inhibitor/fulvestrant, or endocrine monotherapy, or chemotherapy as first-line treatment in women with HR-positive, HER2-negative locally advanced or metastatic breast cancer: Third interim analysis from the RIBANNA study

10.1158/1538-7445.sabcs20-ps10-16 ◽

2021 ◽

Author(s):

Achim Wöckel ◽

Cosima Brucker ◽

Thomas Decker ◽

Jörg Falbrede ◽

Helmut Forstbauer ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Aromatase Inhibitor ◽

Interim Analysis ◽

Locally Advanced ◽

Metastatic Breast ◽

Line Treatment ◽

First Line Treatment

Download Full-text

321P First-line treatment patterns in HR+/HER2- locally advanced or metastatic breast cancer in Europe

Annals of Oncology ◽

10.1016/j.annonc.2020.08.423 ◽

2020 ◽

Vol 31 ◽

pp. S371-S372

Author(s):

K. Lewis ◽

S. Kurosky ◽

M. Last ◽

D. Mitra ◽

A. Lambert ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Locally Advanced ◽

Metastatic Breast ◽

Treatment Patterns ◽

Line Treatment ◽

First Line Treatment

Download Full-text

A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer

European Journal of Cancer ◽

10.1016/j.ejca.2011.05.005 ◽

2011 ◽

Vol 47 (14) ◽

pp. 2091-2098 ◽

Author(s):

D. Amadori ◽

C. Milandri ◽

G. Comella ◽

S. Saracchini ◽

S. Salvagni ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Liposomal Doxorubicin ◽

Locally Advanced ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin ◽

Line Treatment ◽

Her 2 ◽

First Line Treatment

Download Full-text

Pertuzumab and Trastuzumab in Combination with Vinorelbine for First-Line Treatment of Patients with HER2-Positive Locally Advanced or Metastatic Breast Cancer (LABC/MBC): A Single-Arm, Two-Cohort, Phase II Study (Velvet)

Annals of Oncology ◽

10.1016/s0923-7534(20)32976-8 ◽

2012 ◽

Vol 23 ◽

pp. ix142

Author(s):

M. Andersson ◽

J.M. Lopez-Vega ◽

L. Del Mastro ◽

T. Petit ◽

L. Mitchell ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Metastatic Breast ◽

Line Treatment ◽

Her2 Positive ◽

First Line Treatment

Download Full-text

Real-world effectiveness of ribociclib + aromatase inhibitor, or endocrine monotherapy, or chemotherapy as first-line treatment in postmenopausal women with HR-positive, HER2-negative locally advanced or metastatic breast cancer: The RIBANNA study

Annals of Oncology ◽

10.1093/annonc/mdy271.275 ◽

2018 ◽

Vol 29 ◽

pp. viii89

Author(s):

P.A. Fasching ◽

T. Decker ◽

G. Guderian ◽

J. Heim ◽

C. Jackisch ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Locally Advanced ◽

Metastatic Breast ◽

Line Treatment ◽

First Line Treatment

Download Full-text

A multicenter randomized phase III trial of nonpegylated liposome-encapsulated doxorubicin citrate plus cyclophosphamide (MC) versus liposome-encapsulated doxorubicin citrate plus vinorelbine (MV) as first-line treatment in locally advanced (LABC) or metastatic breast cancer (MBC).

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.1041 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 1041-1041

Author(s):

V. Lorusso ◽

F. Giotta ◽

R. Bordonaro ◽

E. Maiello ◽

S. Del Prete ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Locally Advanced ◽

Metastatic Breast ◽

Phase Iii ◽

Line Treatment ◽

Phase Iii Trial ◽

First Line Treatment

Download Full-text

A Phase II Multicenter Study of Two Different Dosages of Pemetrexed Given in Combination With Cyclophosphamide as First-Line Treatment in Patients With Locally Advanced or Metastatic Breast Cancer

Cancer Investigation ◽

10.3109/07357907.2012.658938 ◽

2012 ◽

Vol 30 (4) ◽

pp. 309-316 ◽

Author(s):

Christian Dittrich ◽

Ewa Solska ◽

Alexey Manikhas ◽

Alexandru Eniu ◽

Sergei Tjulandin ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Multicenter Study ◽

Locally Advanced ◽

Metastatic Breast ◽

Line Treatment ◽

First Line Treatment

Download Full-text

Phase II study of liposomal doxorubicin (Myocet®), docetaxel and trastuzumab combination as first line treatment of patients with her-2/neu positive locally advanced or metastatic breast cancer.

10.1158/0008-5472.sabcs-3149 ◽

2009 ◽

Author(s):

D Amadori ◽

G Gasparini ◽

A Ardizzoni ◽

G Comella ◽

S Saracchini ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Locally Advanced ◽

Metastatic Breast ◽

Line Treatment ◽

Her 2 ◽

First Line Treatment

Download Full-text

Abstract P1-19-33: Real-world efficacy of ribociclib + aromatase inhibitor, or endocrine monotherapy, or chemotherapy as first-line treatment in postmenopausal women with HR-positive, HER2-negative locally advanced or metastatic breast cancer: Second interim analysis from the RIBANNA study

10.1158/1538-7445.sabcs19-p1-19-33 ◽

2020 ◽

Author(s):

Achim Wöckel ◽

Pawel Basiora ◽

Michael Bohlmann ◽

Thomas Decker ◽

Jörg Falbrede ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Aromatase Inhibitor ◽

Interim Analysis ◽

Locally Advanced ◽

Metastatic Breast ◽

Line Treatment ◽

First Line Treatment

Download Full-text